Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium

1Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

The national vaccination campaign against SARS-CoV-2 started in January 2021 in Belgium. In the present study, we aimed to use national hospitalisation surveillance data to investigate the recent evolution of vaccine impact on the risk of COVID-19 hospitalisation. We analysed aggregated data from 27,608 COVID-19 patients hospitalised between October 2021 and February 2022, stratified by age category and vaccination status. For each period, vaccination status, and age group, we estimated risk ratios (RR) corresponding to the ratio between the probability of being hospitalised following SARS-CoV-2 infection if belonging to the vaccinated population and the same probability if belonging to the unvaccinated population. In October 2021, a relatively high RR was estimated for vaccinated people > 75 years old, possibly reflecting waning immunity within this group, which was vaccinated early in 2021 and invited to receive the booster vaccination at that time. In January 2022, a RR increase was observed in all age categories coinciding with the dominance of the Omicron variant. Despite the absence of control for factors like comorbidities, previous infections, or time since the last administered vaccine, we showed that such real-time aggregated data make it possible to approximate trends in vaccine impact over time.

References Powered by Scopus

Dexamethasone in hospitalized patients with covid-19

7730Citations
N/AReaders
Get full text

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

1583Citations
N/AReaders
Get full text

Waning immune humoral response to BNT162B2 COVID-19 vaccine over 6 months

1267Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Erazo, D., Vincenti-Gonzalez, M. F., van Loenhout, J. A. F., Hubin, P., Vandromme, M., Maes, P., … Dellicour, S. (2022). Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium. Viruses, 14(6). https://doi.org/10.3390/v14061315

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

67%

Lecturer / Post doc 2

17%

Professor / Associate Prof. 1

8%

Researcher 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

55%

Nursing and Health Professions 3

27%

Pharmacology, Toxicology and Pharmaceut... 1

9%

Neuroscience 1

9%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
Social Media
Shares, Likes & Comments: 8

Save time finding and organizing research with Mendeley

Sign up for free